NLRP3 and lymphoma: For most lymphomas, specifically DLBCL [83,113], MALT lymphoma [89,114], MCL [90], PEL [91], and ΝΚ/Τ-cell lymphoma [129], NLRP3 inflammasome activation seems to exert a pro-tumorigenic effect.